| h Uniphy Elektromedizin GmbH & Co. KG
u nN | p y ; NeuendorfstraRe 19 b
MAR ES 2005 D-16761 Hennigsdort
‘ Germany
Elektromedizin
Abbreviated 510(k) submission for cryflow 700 and cryflow 1000.
510(k) Summary KO Ss a 310
a
Date prepared: August 19, 2005
Submitter: Uniphy Elektromedizin GmbH & Co. KG
19B NeuendorferstraRe
16761 Hennigsdorf
Germany
Contact Name: ... Reiner Tostmann, Doc-Eng
Phone Number: .. 11-49-3302-50440
FAX Number: ..... 11-49-3302-504499
E-mail: ................ Reiner. Tostmann@uniphy-elmed.com
Device trade name: Cryoflow 700, Cryflow 1000
Common name: Skin Refrigerant
Classification name: Class 2 (21CFR 878.4810) 78 GEX
Laser surgery instrument for use in general and plastic
surgery and dermatology.
Description of device: The Cryofiow 700 and Cryoflow 1000 consists of a refrigeration unit
that creates cold air. The cold air is blown onto the skin
using an air hose.
Performance Standards: None established (as a medical device) under section 514
Intended use of the device: The Cryoflow 700 and Cryoflow 1000 are intended to minimize
pain and thermal injury during laser and dermatological
treatments and for temporary topical anesthetic relief for
injections.
Substantial equivalence claim to the following legally marketed device:
Cryo 5 (Zimmer). K040727
Summary of substantial equivalence:
The Uniphy Cryoflow 700 and Cryflow 1000 are substantially equivalent to the compared device on the
basis of similarities in operating principles, intended use and functional performance
1—9

. £ 4 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
% ‘gj
vom Food and Drug Administration
9200 Corporate Boulevard
WAR 15 2006 Rockville MD 20850
Gymnauniphy N.V.
c/o Nico Beun
Uniphy Elektromedizin GmbH & Co. KG
Pasweg 6A.
Belzen 3740
Belgium
Re: K052310
Trade/Device Name: Cryoflow 700, Cryflow 1000
Regulation Number: 2] CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic
surgery and in dermatology
Regulatory Class: I]
Product Code: GEX
Dated: August 22, 2005
Received: August 24, 2005
Dear Nico Beun:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
if your device is classified (see above) into cither class II (Special Controls) or class If] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including. but not limited to: registration and listing (21
CFR Part 807); labeling (2! CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2- Nico Beun
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device ~
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gow/cdrh/industry/support/index him)

Sincerely yours,

> Mark N. Melkerson
Acting Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

: DCN: K052310
U Nn p hy Uniphy Elektromedizin GmbH & Co. KG
Neuendorfstrake 19 b
a D-16761 Hennigsdorf
Elektromedizin Germany
Indications for Use :
510(k) Number (if known): K052310 .
Device Name: Cryoflow 700, Cryoflow 1000
- Indications for Use:

- The Cryoflow 700 and Cryoflow 1000 are intended to minimize pain and thermal injury
during laser and dermatological treatments and for temporary topical anesthetic relief for
injections.

Prescription Use __ Yes AND/OR Over-The-Counter Use _ No
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
one aOR
Division of {,enersi, Restorative,
and Neuroh-cicai Devices
Ko$23 Page _1_ of _I_
510(k) Nuwisr. SOS2>y
(Posted November 13, 2003)
1—7

